Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33017175.
- Also identified by DOI 10.7326/M20-5831 and PMC identifier 7556654.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
These rapid and living practice points from the American College of Physicians address the effectiveness and harms of remdesivir treatment in patients with COVID-19.
Medical subject headings
- Adenosine Monophosphate
- Alanine
- Antiviral Agents
- COVID-19 Drug Treatment